TransBiotec, Inc.
US ˙ OTC
DENNA SYMBOL ÄR INTE LÄNGRE AKTIV

SecurityIMLE / TransBiotec, Inc.
InsiderGary John Graham
This page shows the track record and history of Graham Gary John insider trades in TransBiotec, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Gary John Graham in IMLE / TransBiotec, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2024-05-28 98,744 0.6900 1,646 41.4000 68,133 143 10.2600 -51,255 -75.23
2024-03-06 2,316 0.6100 39 36.6000 1,413
2024-02-29 8,582 0.6200 143 37.2000 5,321
2024-02-26 1,016 0.7200 17 43.2000 732
2020-12-15 2,743,169 66,907
2020-12-07 3,103,028 1,551,514.0000 75,684 63,612,074.0000 4,814,391,384,392
2020-06-05 0 0.0000 0 0.0000 0
2020-06-05 0 0.0000 0 0.0000 0
2020-02-15 0 0.0000 0 0.0000 0
2019-12-12 0 0.0000 0 0.0000 0

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IMLE / TransBiotec, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Gary John Graham in IMLE / TransBiotec, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IMLE / TransBiotec, Inc. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2024-05-29 2024-05-28 4 Graham Gary John SOBR Common Stock P - Purchase D 0.6900 -98,744 -68 0
2024-03-07 2024-03-06 4 Graham Gary John SOBR Common Stock P - Purchase D 0.6100 -2,316 -1 98,744
2024-03-01 2024-02-29 4 Graham Gary John SOBR Common Stock P - Purchase D 0.6200 -8,582 -5 103,060
2024-03-01 2024-02-26 4 Graham Gary John SOBR Common Stock P - Purchase D 0.7200 -1,016 -1 111,642
2024-01-30 2023-06-12 5 Graham Gary John By First Capital Holdings, LLC SOBR Common Stock C - Conversion I 666,667 2,542,616
2024-01-30 2023-06-12 5 Graham Gary John SOBR Common Stock C - Conversion D 666,667 2,542,616
2024-01-30 2022-06-30 5 Graham Gary John By SOBR SAFE, LLC SOBR Common Stock J - Other I -888,750 25,639
2024-01-30 2022-06-30 5 Graham Gary John SOBR Common Stock J - Other D -888,750 25,639
2024-01-30 2022-03-01 5 Graham Gary John By IDTEC, LLC SOBR Common Stock J - Other I -2,000,000 2,711,923
2024-01-30 2022-03-01 5 Graham Gary John SOBR Common Stock J - Other D -2,000,000 2,711,923
2024-01-30 2022-01-20 5 Graham Gary John By IDTEC, LLC SOBR Common Stock X - Other I 0.5000 176,938 88 2,711,923
2024-01-30 2022-01-20 5 Graham Gary John SOBR Common Stock X - Other D 0.5000 176,938 88 2,711,923
2024-01-30 2020-12-31 5 Graham Gary John By IDTEC, LLC SOBR Common Stock C - Conversion I 3,103,028 11,322,575
2024-01-30 2020-12-31 5 Graham Gary John SOBR Common Stock C - Conversion D 3,103,028 11,322,575
2024-01-30 2020-12-30 5 Graham Gary John By IDTEC, LLC SOBR Common Stock J - Other I -3,128,896 11,322,575
2024-01-30 2020-12-30 5 Graham Gary John SOBR Common Stock J - Other D -3,128,896 11,322,575
2024-01-30 2020-12-15 5 Graham Gary John By SOBR SAFE, LLC SOBR Common Stock C - Conversion I 1.0000 2,743,169 2,743 2,743,169
2024-01-30 2020-12-15 5 Graham Gary John SOBR Common Stock C - Conversion D 1.0000 2,743,169 2,743 2,743,169
2024-01-30 2020-09-23 5 Graham Gary John By IDTEC, LLC SOBR Common Stock J - Other I -1,025,829 11,322,575
2024-01-30 2020-09-23 5 Graham Gary John SOBR Common Stock J - Other D -1,025,829 11,322,575
2020-12-31 2020-12-15 4 Graham Gary John SOBR SAFE, LLC SOBR 8% Series A-1 Preferred Stock C - Conversion I 1.00 0 0
2020-12-31 2020-12-15 4 Graham Gary John SOBR SAFE, LLC SOBR Common Stock P - Purchase I 2,743,169 17,846,197
2020-12-31 2020-12-07 4 Graham Gary John IDTEC, LLC SOBR Convertible Promissory Note C - Conversion I 0.50 0 0
2020-12-31 2020-12-07 4 Graham Gary John IDTEC, LLC SOBR Common Stock P - Purchase I 1,551,514.0000 3,103,028 4,814,391,384 15,103,028
2020-06-23 2020-06-05 4 Graham Gary John By IDTEC, LLC IMLED Convertible Note A - Award I 0.50 12,320,000
2020-06-23 2020-06-05 4 Graham Gary John By IDTEC LLC IMLED Warrants A - Award I 0.50 160,000.0000 320,000 51,200,000 12,320,000
2020-06-23 2020-06-05 4 Graham Gary John By IDTEC, LLC IMLED Common Stock A - Award I 12,000,000 12,000,000
2020-06-22 2020-06-05 4/A Graham Gary John IMLED Common Stock P - Purchase D 0 0
2020-06-22 2020-06-05 4/A Graham Gary John IMLED Common Stock P - Purchase D 0 0
2020-03-10 2020-02-15 4 Graham Gary John IMLE Common Stock P - Purchase D 0 0
2020-03-10 2019-12-12 4 Graham Gary John SOBR SAFE, LLC IMLE Series A-1 Convertible Preferred Stock P - Purchase I 0.00 1,000,000.0000 1,000,000 1,000,000,000 1,000,000
2020-03-10 2019-12-12 4 Graham Gary John IMLE Common Stock P - Purchase D 0 0
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)